Breaking News Instant updates and real-time market news.

SMAR

Smartsheet

$43.93

-3.5 (-7.38%)

12:00
12/02/19
12/02
12:00
12/02/19
12:00

Smartsheet falls -7.5%

Smartsheet is down -7.5%, or -$3.57 to $43.86.

  • 02

    Dec

  • 04

    Dec

  • 10

    Dec

  • 11

    Dec

SMAR Smartsheet
$43.93

-3.5 (-7.38%)

10/11/19
OPCO
10/11/19
NO CHANGE
OPCO
Oppenheimer lowers price targets for MongoDB, Twilio, New Relic ahead of reports
Oppenheimer analyst Ittai Kidron said he expects solid results from the Analytics, Collaboration, and Infrastructure software group, though upside may be more constrained given several vendors face tougher year-over year comparisons and it seems investors have become more sensitive to high valuations. While he said MongoDB (MDB), Twilio (TWLO), Smartsheet (SMAR) and Elastic (ESTC) remain top picks, he sees lower near-term upside given tough comps in the second half and sees them as better positioned to deliver bigger upside in calendar 2020, Kidron tells investors in his group preview. Ahead of results from the group, Kidron lowered his price target for MongoDB to $155 from $180, for Twilio to $145 from $160 and for New Relic (NEWR) to $80 from $85. He also noted that he is bullish on Alteryx (AYX), Atlassian (TEAM) and VMware (VMW).
11/11/19
WEDB
11/11/19
DOWNGRADE
WEDB
Neutral
Smartsheet downgraded to Neutral from Outperform at Wedbush
Wedbush analyst Steve Koenig downgraded Smartsheet to Neutral from Outperform.
11/11/19
WEDB
11/11/19
DOWNGRADE
Target $42
WEDB
Neutral
Smartsheet downgraded to Neutral at Wedbush, price target slashed to $42
Wedbush analyst Steve Koenig downgraded Smartsheet (SMAR) to Neutral from Outperform with a price target of $42, down from $62, citing intensifying competition and says checks pointing to anecdotally short tenures in the sales organization are "somewhat concerning." In a research note to investors, Koenig says he was willing to look past slight deceleration in Q2 and a smaller guidance raise, but says Microsoft's (MSFT) October 29 rollout of a redesigned Project, with new integrations and subscription plans, raises the level of risk around Smartsheet's momentum.
11/12/19
FANA
11/12/19
INITIATION
Target $50
FANA
Outperform
Smartsheet initiated with an Outperform at First Analysis
First Analysis analyst Terry Kiwala initiated coverage of Smartsheet with an Outperform rating and $50 price target. The analyst believes the company can grow its revenue well in excess of 30% in the medium term "while leveraging its efficient sales motion to ultimately become highly profitable."

TODAY'S FREE FLY STORIES

WST

West Pharmaceutical

$146.32

-0.14 (-0.10%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Hot Stocks
West Pharmaceutical announces 848K share repurchase authorization »

On December 10, 2019, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Earnings
Amarin sees FY20 revenue $650M-$700M, consensus $654.55M »

With respect to 2020,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

IBIO

iBio

$0.22

-0.0179 (-7.43%)

17:01
12/13/19
12/13
17:01
12/13/19
17:01
Hot Stocks
iBio receives NYSE noncompliance notice »

iBio, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLT

Applied Therapeutics

$21.23

0.29 (1.38%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Syndicate
Breaking Syndicate news story on Applied Therapeutics »

Applied Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Earnings
Amarin raises FY19 revenue view to $410M-$425M from $380M-$420M 

FY19 consensus $410.25M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

BIO

Bio-Rad

$354.69

-8.005 (-2.21%)

16:56
12/13/19
12/13
16:56
12/13/19
16:56
Hot Stocks
Bio-Rad progressing from ransomware attack recovery detected on Dec 5th »

Bio-Rad Laboratories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:50
12/13/19
12/13
16:50
12/13/19
16:50
Hot Stocks
Amarin confirms FDA approval of Vascepa »

Amarin announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

FRTA

Forterra

$10.69

0.11 (1.04%)

16:46
12/13/19
12/13
16:46
12/13/19
16:46
Syndicate
Breaking Syndicate news story on Forterra »

Forterra files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:45
12/13/19
12/13
16:45
12/13/19
16:45
Hot Stocks
Amarin receives FDA approval of Vascepa »

The U.S. FDA approved the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

SPY

SPDR S&P 500 ETF Trust

$317.27

0.13 (0.04%)

, SPX

S&P 500

$0.00

(0.00%)

16:37
12/13/19
12/13
16:37
12/13/19
16:37
Periodicals
SCOTUS to hear three cases on Trump's financial records, CNBC reports »

The U.S. Supreme Court…

SPY

SPDR S&P 500 ETF Trust

$317.27

0.13 (0.04%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CME

CME Group

$204.61

1.47 (0.72%)

16:34
12/13/19
12/13
16:34
12/13/19
16:34
Hot Stocks
CME Group CEO Duffy sells 39,309 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

GLG

China Bat Group

$1.81

-0.055 (-2.95%)

16:33
12/13/19
12/13
16:33
12/13/19
16:33
Hot Stocks
China Bat Group regains compliance with Nasdaq »

China Bat Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

16:32
12/13/19
12/13
16:32
12/13/19
16:32
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPX Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HZNP

Horizon Pharma

$32.84

(0.00%)

16:30
12/13/19
12/13
16:30
12/13/19
16:30
Hot Stocks
Breaking Hot Stocks news story on Horizon Pharma »

Horizon Pharma trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

16:30
12/13/19
12/13
16:30
12/13/19
16:30
Options
Preliminary option volume of 31.3M today »

Preliminary option volume…

ORCL

Oracle

$54.49

-1.98 (-3.51%)

, ADBE

Adobe

$316.89

11.13 (3.64%)

16:27
12/13/19
12/13
16:27
12/13/19
16:27
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks were on a…

ORCL

Oracle

$54.49

-1.98 (-3.51%)

ADBE

Adobe

$316.89

11.13 (3.64%)

RBS

RBS

$6.81

0.65 (10.55%)

BCS

Barclays

$9.73

0.65 (7.16%)

LYG

Lloyds Banking

$3.43

0.235 (7.37%)

T

AT&T

$38.24

-0.11 (-0.29%)

LYV

Live Nation

$64.23

-5.21 (-7.50%)

SRPT

Sarepta

$132.00

31.61 (31.49%)

TNDM

TNDM

ATNX

Athenex

$14.56

-2.38 (-14.05%)

AVGO

Broadcom

$315.37

-12.02 (-3.67%)

COST

Costco

$291.88

-5.62 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 23

    Jan

  • 29

    Jan

  • 05

    Mar

VKTX

Viking Therapeutics

$7.94

0.045 (0.57%)

16:26
12/13/19
12/13
16:26
12/13/19
16:26
Conference/Events
Viking Therapeutics management to meet with SVB Leerink »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

VCYT

Veracyte

$28.50

-0.16 (-0.56%)

16:24
12/13/19
12/13
16:24
12/13/19
16:24
Conference/Events
Veracyte management to meet with SVB Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 17

    Dec

MCK

McKesson

$140.56

-3.44 (-2.39%)

16:21
12/13/19
12/13
16:21
12/13/19
16:21
Conference/Events
McKessonto hold a sell-side analyst meeting »

Sell-Side Analyst Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

MDR

McDermott

$0.82

0.0412 (5.31%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Hot Stocks
McDermott discloses NYSE delisting notice »

McDermott announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$114.26

-1.52 (-1.31%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Conference/Events
Intercept to hold a meeting for investors »

Management holds NASH…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 26

    Mar

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Options
Closing CBOE SPX and VIX Index summary for December 13th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPWR

Ideal Power

$2.45

0.04 (1.66%)

16:19
12/13/19
12/13
16:19
12/13/19
16:19
Syndicate
Breaking Syndicate news story on Ideal Power »

Ideal Power files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIE

Erie Indemnity

$168.97

0.25 (0.15%)

16:18
12/13/19
12/13
16:18
12/13/19
16:18
Hot Stocks
Erie Indemnity increases quarterly dividend »

The board of Erie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

ESRT

Empire State Realty

$13.68

0.055 (0.40%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Hot Stocks
Empire State Realty renews $500M stock repurchase program »

Empire State Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.